SAR 29.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 441.99 Million SAR | 32.17% |
2022 | 334.42 Million SAR | 10.29% |
2021 | 303.23 Million SAR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 473.1 Million SAR | 7.04% |
2023 FY | 441.99 Million SAR | 32.17% |
2023 Q4 | 441.99 Million SAR | 9.12% |
2023 Q2 | 405.07 Million SAR | 21.12% |
2022 Q4 | 334.42 Million SAR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 444.89 Million SAR | 0.652% |
Al-Dawaa Medical Services Company | 4.7 Billion SAR | 90.611% |
Nahdi Medical Company | 5.37 Billion SAR | 91.771% |
Al-Razi Medical Co. | 45.41 Million SAR | -873.185% |